Skip to main content
. 2020 Jan;45(1):50–58. doi: 10.30476/ijms.2019.44972

Table2.

Results of cytotoxicity for gefitinib and regorafenib in RR-HCT116 and parental HCT116

Drug IC50 (µM) Resistance index b
RRa sub-line HCT116
gefitinib 19.53±0.98 10.16±0.21 1.92
regorafenib 64.99±1.32 44.95±1.92 1.45
a

Radioresistant;

b

Ratio of IC50 drug dose in resistant sub-line to that in parental